Solid vaccine eliminates acute myeloid leukemia in mice

A new study presents an alternative treatment for acute myeloid leukemia (AML) that has the potential to eliminate AML cells completely.

Lindsay Brownell
Jan. 14, 2020 | harvard

~10 mins   

Tags: health-medicine acute-myeloid-leukemia-aml aml basic-research biomaterial-based-vaccine harvards-wyss-institute-for-biologically-inspired-engineering john-a-paulson-school-of-engineering-and-applied-sciences

Harvard chemist teases out why drugs work (or don’t)

Assistant Professor Brian Liau of the Chemistry and Chemical Biology Department has answered the question of why some new drugs for acute myeloid leukemia don’t work by combining CRISPR gene editing with small-molecule inhibitor treatments in a technique he calls CRISPR-suppressor scanning.

Caitlin McDermott-Murphy
May 6, 2019 | harvard

~7 mins   

Tags: science-technology acute-myeloid-leukemia aml brian-liau chemistry chemistry-and-chemical-biology crispr leukemia nature-chemical-biology

Page 1 of 1